MeSH tree: C10.292
A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical trial co-led by UCL and Moorfields ...
Sep 15, 2025
0
24
Today, when an aging parent, relative, or friend starts to forget things, a firm diagnosis can be surprisingly elusive.
Sep 4, 2025
0
21
For decades, amblyopia has been considered a disorder primarily caused by abnormal visual experiences early in life. But new research from Mary Whitman, MD, Ph.D., pediatric ophthalmologist in the Department of Ophthalmology ...
Aug 12, 2025
0
34
In a new study led by Children's Hospital of Philadelphia (CHOP), researchers found that novel eye-tracking metrics can help properly identify concussion-related vision disorders, a common phenomenon among patients with persisting ...
Jul 30, 2025
0
12
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional therapies, according to ...
Jul 21, 2025
0
13
Much of the pre-series attention on the 2025 British and Irish Lions tour of Australia has been on injuries, player omissions and personal rivalries.
Jul 21, 2025
0
18
Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged retinal tissue. It offers a gentle, biocompatible way to stabilize the inner eye environment and may assist ...
Jul 9, 2025
0
15
Artificial intelligence is playing an increasingly vital role in modern medicine, particularly in interpreting medical images to help clinicians assess disease severity, guide treatment decisions and monitor disease progression. ...
Jun 4, 2025
0
23
The University of Liverpool's Professor Fiona Rowe has led the development of a major new international clinical guideline addressing visual impairment in stroke survivors. Released by the European Stroke Organization (ESO), ...
Jun 2, 2025
0
15
National Institutes of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the plant-derived molecule resiniferatoxin (RTX) shows that it is a safe and effective agent for pain control ...
May 30, 2025
1
47
